Literature DB >> 11579681

Paucicellular variant of anaplastic thyroid carcinoma: report of two cases.

J C Canos1, A Serrano, X Matias-Guiu.   

Abstract

The paucicellular variant of anaplastic carcinoma is an infrequent type of thyroid tumor. It was described as a tumor characterized by very low cellularity and prominent fibrosis, probably secondary to extensive infarction. These features could lead to an erroneous diagnosis of Riedel's thyroiditis. In this paper, we report the clinical and pathological features of two new cases of this unusual entity. Tumor cells were negative for thyroglobulin immunostaining and positive for keratins and p53. Although the number of reported cases is small, the cumulative data on these two cases and the previously reported ones lead us to suggest that the paucicellular variant may occur in younger patients than the conventional anaplastic thyroid carcinoma and that the tumor may be associated with a less aggressive tendency to local progression and metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579681     DOI: 10.1385/ep:12:2:157

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  14 in total

1.  p53 in a thyroid follicular carcinoma with foci of poorly differentiated and anaplastic carcinoma.

Authors:  X Matias-Guiu; A Villanueva; M Cuatrecasas; G Capella; A De Leiva; J Prat
Journal:  Pathol Res Pract       Date:  1996-12       Impact factor: 3.250

2.  Anaplastic thyroid carcinoma survival.

Authors:  P E Voutilainen; M Multanen; R K Haapiainen; A K Leppäniemi; A H Sivula
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

3.  Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma.

Authors:  Y Dobashi; A Sakamoto; H Sugimura; M Mernyei; M Mori; T Oyama; R Machinami
Journal:  Am J Surg Pathol       Date:  1993-04       Impact factor: 6.394

4.  Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid.

Authors:  P Soares; J Cameselle-Teijeiro; M Sobrinho-Simões
Journal:  Histopathology       Date:  1994-03       Impact factor: 5.087

5.  Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas.

Authors:  Y Dobashi; H Sugimura; A Sakamoto; M Mernyei; M Mori; T Oyama; R Machinami
Journal:  Diagn Mol Pathol       Date:  1994-03

6.  Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.

Authors:  R Donghi; A Longoni; S Pilotti; P Michieli; G Della Porta; M A Pierotti
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

7.  Undifferentiated and poorly differentiated carcinoma.

Authors:  J Rosai; E A Saxén; L Woolner
Journal:  Semin Diagn Pathol       Date:  1985-05       Impact factor: 3.464

8.  Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland.

Authors:  T Ito; T Seyama; T Mizuno; N Tsuyama; T Hayashi; Y Hayashi; K Dohi; N Nakamura; M Akiyama
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

9.  Paucicellular variant of anaplastic thyroid carcinoma. A mimic of Reidel's thyroiditis.

Authors:  S K Wan; J K Chan; S K Tang
Journal:  Am J Clin Pathol       Date:  1996-04       Impact factor: 2.493

10.  Anaplastic carcinoma of the thyroid: a clinicopathologic study of 82 cases.

Authors:  C J Nel; J A van Heerden; J R Goellner; H Gharib; W M McConahey; W F Taylor; C S Grant
Journal:  Mayo Clin Proc       Date:  1985-01       Impact factor: 7.616

View more
  7 in total

Review 1.  Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.

Authors:  Eleonora Molinaro; Cristina Romei; Agnese Biagini; Elena Sabini; Laura Agate; Salvatore Mazzeo; Gabriele Materazzi; Stefano Sellari-Franceschini; Alessandro Ribechini; Liborio Torregrossa; Fulvio Basolo; Paolo Vitti; Rossella Elisei
Journal:  Nat Rev Endocrinol       Date:  2017-07-14       Impact factor: 43.330

2.  Malignant peripheral nerve sheath tumor of the thyroid: a clinicopathological and ultrastructural study of one case.

Authors:  Judit Pallares; Luis Perez-Ruiz; Susana Ros; Ma Jose Panades; Javier Pardo-Mindan; Josep Lloreta; Xavier Matias-Guiu
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

Review 3.  Thyroid Gland Solitary Fibrous Tumor: Report of 3 Cases and a Comprehensive Review of the Literature.

Authors:  Lester D R Thompson; Christina Wei; Lisa M Rooper; Sean K Lau
Journal:  Head Neck Pathol       Date:  2019-02-13

Review 4.  Case of concurrent Riedel's thyroiditis, acute suppurative thyroiditis, and micropapillary carcinoma.

Authors:  Ji Taek Hong; Jung Hwan Lee; So Hun Kim; Seong Bin Hong; Moonsuk Nam; Yong Seong Kim; Young Chae Chu
Journal:  Korean J Intern Med       Date:  2013-02-27       Impact factor: 2.884

Review 5.  Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.

Authors:  Moira Ragazzi; Alessia Ciarrocchi; Valentina Sancisi; Greta Gandolfi; Alessandra Bisagni; Simonetta Piana
Journal:  Int J Endocrinol       Date:  2014-08-21       Impact factor: 3.257

6.  Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report.

Authors:  Cristina Luongo; Tommaso Porcelli; Francesca Sessa; Maria Angela De Stefano; Francesco Scavuzzo; Vincenzo Damiano; Michele Klain; Claudio Bellevicine; Elide Matano; Giancarlo Troncone; Martin Schlumberger; Domenico Salvatore
Journal:  Curr Oncol       Date:  2021-12-16       Impact factor: 3.677

Review 7.  Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.

Authors:  Ichiro Abe; Alfred King-Yin Lam
Journal:  Histol Histopathol       Date:  2020-11-10       Impact factor: 2.303

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.